Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism

Cardiovascular Research

Volumn 78, Issue 3, 2008, Pages 546-553

  Ha, Tuanzhu ^a   Hua, Fang ^a   Liu, Xiang ^a   Ma, Jing ^a   McMullen, Julie R ^b,c   Shioi, Tetsuo ^b   Izumo, Seigo ^b   Kelley, Jim ^a   Gao, Xiag ^d   Browder, William ^a   Williams, David L ^a   Kao, Race L ^a   Li, Chuanfu ^a  

^a East Tennessee State University   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d NANJING UNIVERSITY   (China)

Author keywords

Cardioprotection; Lipopolysaccharide; Myocardium; PI3K Akt activity; TLR NF B pathway

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 27; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE CONTROL; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CASPASE 3; CHROMONES; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HEAT-SHOCK PROTEINS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, TRANSGENIC; MORPHOLINES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 44449085285     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn037     Document Type: Article

References (38)

1. Brown JM, Grosso MA, Terada LS, Whitman GJR. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 1989;86:2516-2520.
2. Yao Z, Auchampach JA, Pieper GM, Gross G. Cardioprotective effects of monophosphoryl lipid-A, a novel endotoxin analogue, in dog. Cardiovasc Res 1993;27:832-838.
3. Zacharowski K, Frank S, Otto M, Chatterjee PK, Cuzzocrea S, Hafner G et al. Lipoteichoic acid induces delayed protection in the rat heart, a comparison with endotoxin. Arterioscler Thromb Vasc Biol 2000;20:1521-1528.
4. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL et al. Modulating Toll-like receptor mediated signaling by (1->3)-β-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2003;61:538-547.
5. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994;89:2421-2432.
6. Li C, Browder W, Kao RL. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am J Physiol 1999;276:H543-H552.
7. Li C, Kao RL, Ha T, Kelley J, Browder IW, Williams DL. Early activation of IKKβ during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H1264-H1271.
8. Li C, Ha T, Liu L, Browder W, Kao RL. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. Surgery 2000;127:161-169.
9. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997;3:894-899.
10. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA et al. Reduced myocardial ischemia-reperfusion injury in Toll-like receptor 4-deficient mice. Circulation 2004;109:784-789.
11. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X et al. Protection against myocardial ischemia/reperfusion injury in TLR4 deficient mice is mediated through a phosphoinositide 3-kinase dependent mechanism. J Immunol 2007;178:7317-7324.
12. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
13. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-1657.
14. Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur J Immunol 2003;33:597-605.
15. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J et al. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 2004;172:449-456.
16. Guha M, Mackman N. The PI3K-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002;277:32124-32132.
17. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003;24:358-363.
18. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000;101:660-667.
19. Matsui T, Ling L, del Monte F, Fukui Y, Franke TF, Hajjar RJ et al. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999;100:2373-2379.
20. Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 2002;22:2799-2809.
21. Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003;107:1664-1670.
22. Gao J, Chua CC, Chen Z, Wang H, Xu X, Hamdy RC et al. Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol 2007;43:601-609.
23. Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J et al. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 2006;290:H985-H994.
24. Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J et al. Reduced cardiac hypertrophy in Toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 2005;68:224-234.
25. Ha T, Hua F, Grant D, Xia Y, Ma J, Gao X et al. Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. Am J Physiol Heart Circ Physiol 2006;291:H1910- H1918.
26. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005;6:777-784.
27. Jope RS, Johnson GVW. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004;29:96-102.
28. Efthymiou CA, Mocanu MM, de Belleroche J, Wells DJ, Latchmann DS, Yellon DM. Heat shock protein 27 protects the heart against myocardial infarction. Basic Res Cardiol 2004;99:392-394.
29. Liu L, Zhang X, Qian B, Min X, Gao X, Li C et al. Overexpression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Eur J Heart Fail 2007;9:762-769.
30. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
31. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW et al. Overexpression of cardiac I-kBa prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 2001;280:H962-H968.
32. Nemoto S, Vallejo JG, Kneufermann P, Misra A, Defreitas G, Carabello BA et al. Escherichia coli LPS-induced LV dysfunction role of Toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol 2002;282:H2316-H2323.
33. Rajan TV. The scholarly presentation. Scientist 2001;15:38-38.
34. Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, Asano T et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 2002;3:875-881.
35. Williams DL, Ozment-Skelton T, Li C. Modulation of the phosphoinositide-3-kinase signaling pathway alters host resistance to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006;25:432- 439.
36. Arbibe L, Mira J-P, Teusch N, Kline L, Guha M, Mackman N et al. Toll-like receptor 2-mediated NF-κB activation requires a RAC I-dependent pathway. Nat Immunol 2000;1:533-540.
37. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM et al. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 2005;33:1903-1912.
38. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003;284:H456-H463.